AXGN - AxoGen, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
27.40
+0.15 (+0.55%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close27.25
Open27.25
Bid0.00 x 0
Ask0.00 x 0
Day's Range26.95 - 27.57
52 Week Range8.75 - 31.70
Volume168,765
Avg. Volume327,604
Market Cap934.17M
Beta-0.43
PE Ratio (TTM)N/A
EPS (TTM)-0.41
Earnings DateOct 31, 2017 - Nov 6, 2017
Forward Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2010-01-27
1y Target Est32.20
Trade prices are not sourced from all markets
  • Top 3 Growth Stocks For The Month
    Simply Wall St.2 days ago

    Top 3 Growth Stocks For The Month

    Investors tend to look for stocks that have a strong future outlook. Why invest in something that will grow slower than the rest of the market? In terms of profitabilityRead More...

  • GlobeNewswire11 days ago

    AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue

    Q4 Revenue will be at least $16.5 million, representing 45% growth over prior year 2017 Revenue will be at least $60.0 million, representing 46% growth over prior year. ALACHUA, Fla., Jan. 08, 2018-- AxoGen, ...

  • GlobeNewswire14 days ago

    AxoGen to Participate at AAHS ASPN ASRM 2018 Annual Meetings

    ALACHUA, Fla., Jan. 05, 2018-- AxoGen Corporation, a global leader in developing and marketing innovative surgical solutions for peripheral nerve damage, today announced its participation at the combined ...

  • Capital Cube21 days ago

    ETFs with exposure to AxoGen, Inc. : December 29, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AxoGen, Inc. Here are 5 ETFs with the largest exposure to AXGN-US. Comparing the performance and risk of AxoGen, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • GlobeNewswirelast month

    AxoGen Corporation Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float

    ALACHUA, Fla., Dec. 18, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Dylan Harvey was selected to ride ...

  • December Top Growth Stocks To Look Out For
    Simply Wall St.last month

    December Top Growth Stocks To Look Out For

    Stocks that are expected to significantly grow their profitability in the future can add meaningful upside to your portfolio. AxoGen and Select Bancorp are examples of many high-growth stocks thatRead More...

  • Capital Cube2 months ago

    ETFs with exposure to AxoGen, Inc. : December 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AxoGen, Inc. Here are 5 ETFs with the largest exposure to AXGN-US. Comparing the performance and risk of AxoGen, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • GlobeNewswire2 months ago

    AxoGen Announces Closing of Public Offering of Common Stock

    ALACHUA, Fla., Nov. 20, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve damage, today announced the closing of its previously announced ...

  • GlobeNewswire2 months ago

    AxoGen, Inc. (Nasdaq: AXGN) to Ring The Nasdaq Stock Market Opening Bell

    What: AxoGen, a global leader in innovative surgical solutions for peripheral nerve regeneration and repair, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Karen Zaderej, President, ...

  • GlobeNewswire2 months ago

    AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day

    Company Announces Expanded Application to Address Breast Reconstruction Neurotization Following Mastectomy. Company Will Continue Developing its Portfolio of Products Toward Future Applications Including ...

  • Capital Cube2 months ago

    ETFs with exposure to AxoGen, Inc. : November 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AxoGen, Inc. Here are 5 ETFs with the largest exposure to AXGN-US. Comparing the performance and risk of AxoGen, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • November Growth Stocks To Look Out For
    Simply Wall St.2 months ago

    November Growth Stocks To Look Out For

    Individual investors like stocks with a high growth potential. These companies have a strong outlook that can bring a significant upside to your portfolio, regardless of market cyclicality. If yourRead More...

  • GlobeNewswire2 months ago

    AxoGen, Inc. Announces Pricing of Public Offering of Common Stock

    ALACHUA, Fla., Nov. 16, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it has priced an underwritten ...

  • GlobeNewswire2 months ago

    AxoGen, Inc. Announces Proposed Public Offering of Common Stock

    ALACHUA, Fla., Nov. 15, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it has commenced an ...

  • GlobeNewswire2 months ago

    AxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference

    ALACHUA, Fla., Nov. 14, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, President and Chief ...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of AXGN earnings conference call or presentation 1-Nov-17 8:30pm GMT

    Q3 2017 AxoGen Inc Earnings Call

  • AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
    Capital Cube3 months ago

    AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017

    Categories: Yahoo FinanceGet free summary analysis AxoGen, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of AxoGen, Inc. – Thermo Fisher Scientific Inc. and Boston Scientific Corporation (TMO-US and BSX-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 16.05 million, ... Read more (Read more...)

  • Associated Press3 months ago

    AxoGen reports 3Q loss

    The Alachua, Florida-based company said it had a loss of 6 cents per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...

  • GlobeNewswire3 months ago

    AxoGen, Inc. Reports 2017 Third Quarter Financial Results

    ALACHUA, Fla., Nov. 01, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, today reported financial results and business ...

  • Is AxoGen Inc (AXGN) A Financially Sound Company?
    Simply Wall St.3 months ago

    Is AxoGen Inc (AXGN) A Financially Sound Company?

    AxoGen Inc (NASDAQ:AXGN) is a small-cap stock with a market capitalization of USD $671.22M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...

  • Capital Cube3 months ago

    ETFs with exposure to AxoGen, Inc. : October 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AxoGen, Inc. Here are 5 ETFs with the largest exposure to AXGN-US. Comparing the performance and risk of AxoGen, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to AxoGen, Inc. : October 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AxoGen, Inc. Here are 5 ETFs with the largest exposure to AXGN-US. Comparing the performance and risk of AxoGen, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)